Abstract
Cancer therapy has witnessed major advances in the last few decades. However, the conventional therapies have a narrow therapeutic application, and the responses produced are generally unpredictable and are often non-curative. New strategies to combat cancer are being developed, one of the most promising of which is the use of non-genotoxic chemicals that are able to rescue the tumor suppressor function of p53 in cancer cells. In this review, we first discuss: (i) the current knowledge on the role of p53 in determining the fate of human normal and malignant cells following exposure to cancer therapeutic agents; and (ii) the biological consequences of the failure of cancer cells to implement p53-mediated responses in terms of development of highly metastatic “karyoplasts” which exhibit both selfrenewal and treatment-resistant properties. We next provide an update on the potential anticancer properties of diverse types of pharmacological modulators of p53, including histone deacetylase inhibitors (e.g., trichostatin A), aromatase inhibitors (e.g., Anastrozole), and the nuclear export inhibitor leptomycin B. In addition, we highlight the various shortcomings of in vitro assays that are universally used for preclinical evaluation of anti-neoplastic properties of new drugs, and describe alternative cytotoxicity assays that circumvent some of these shortcomings.
Keywords: p53 signaling, pharmacological modulators of p53, cancer therapy, cytotoxicity assays, apoptosis, accelerated senescence
Current Signal Transduction Therapy
Title: Pharmacological Modulation of p53 Function in Cancer Therapy
Volume: 3 Issue: 3
Author(s): Razmik Mirzayans and David Murray
Affiliation:
Keywords: p53 signaling, pharmacological modulators of p53, cancer therapy, cytotoxicity assays, apoptosis, accelerated senescence
Abstract: Cancer therapy has witnessed major advances in the last few decades. However, the conventional therapies have a narrow therapeutic application, and the responses produced are generally unpredictable and are often non-curative. New strategies to combat cancer are being developed, one of the most promising of which is the use of non-genotoxic chemicals that are able to rescue the tumor suppressor function of p53 in cancer cells. In this review, we first discuss: (i) the current knowledge on the role of p53 in determining the fate of human normal and malignant cells following exposure to cancer therapeutic agents; and (ii) the biological consequences of the failure of cancer cells to implement p53-mediated responses in terms of development of highly metastatic “karyoplasts” which exhibit both selfrenewal and treatment-resistant properties. We next provide an update on the potential anticancer properties of diverse types of pharmacological modulators of p53, including histone deacetylase inhibitors (e.g., trichostatin A), aromatase inhibitors (e.g., Anastrozole), and the nuclear export inhibitor leptomycin B. In addition, we highlight the various shortcomings of in vitro assays that are universally used for preclinical evaluation of anti-neoplastic properties of new drugs, and describe alternative cytotoxicity assays that circumvent some of these shortcomings.
Export Options
About this article
Cite this article as:
Mirzayans Razmik and Murray David, Pharmacological Modulation of p53 Function in Cancer Therapy, Current Signal Transduction Therapy 2008; 3 (3) . https://dx.doi.org/10.2174/157436208785699721
DOI https://dx.doi.org/10.2174/157436208785699721 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Medical Implications of Gastrointestinal Vagal Afferent Pathways in Nausea and Vomiting
Current Pharmaceutical Design Inhibiting TLR9 Signaling Stimulates Apoptosis and Cell Cycle Arrest, and Alleviates Angiogenic Property in Human Cervical Cancer Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets FDG-PET Imaging in Large Vessel Vasculitis and Polymyalgia Rheumatica: A Personal View
Current Immunology Reviews (Discontinued) Dimer and Tetramer of Gallic Acid: Facile Synthesis, Antioxidant and Antiproliferative Activities
Letters in Drug Design & Discovery Advances in Colloidal Processing of Rare Earth Particles
Current Smart Materials (Discontinued) Mitochondrial Permeability Transition as Target of Anticancer Drugs
Current Pharmaceutical Design Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Recent Advances in the New Generation Taxane Anticancer Agents
Medicinal Chemistry New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets Fused Xanthone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin
Current Gene Therapy Realizing the Potential of Blueberry as Natural Inhibitor of Metastasis and Powerful Apoptosis Inducer: Tapping the Treasure Trove for Effective Regulation of Cell Signaling Pathways
Anti-Cancer Agents in Medicinal Chemistry Benchmarking Classification Models for Cell Viability on Novel Cancer Image Datasets
Current Bioinformatics Progress in Self-assembling Peptide-based Nanomaterials for Biomedical Applications
Current Topics in Medicinal Chemistry Dysregulation of Neurotrophic and Haematopoietic Growth Factors in Alzheimer’s Disease: From Pathophysiology to Novel Treatment Strategies
Current Alzheimer Research The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
Current Cancer Drug Targets Medical Perspective of Childhood Marriage in Nigeria: Body of Evidence from 2013 Nigeria Demographic and Health Survey
Current Women`s Health Reviews Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update
Current Pharmaceutical Design